Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs ...
The liver is one of the vital internal organs of the body. Its job is to detoxify, break down fats, process nutrients and keep the system running, although the contemporary diet, environmental factors ...
According to the American Liver Foundation, about 100 million people in the United States are estimated to have Metabolic dysfunction-associated steatotic liver disease or fatty liver disease. While ...
If every afternoon, like clockwork, you find yourself at the vending machine punching in the code for your daily Diet Coke, you may want to rethink your selection. According to a newly released study, ...
Doctors in China say they transplanted a genetically modified pig liver into a 71-year-old man who lived 171 days after the procedure, and 38 of those days were with the pig organ in place – a first ...
Just one can a day of an artificially sweetened drink can lead to a higher risk of liver disease than its sugary equivalent, a major new study has found. Affecting over 30 per cent of people globally, ...
People could be at higher risk of fatty liver disease from both sugary sodas and diet drinks, a new study says. In fact, artificially sweetened drinks might pose a greater threat to liver health than ...
Using two types of cardiovascular drugs together could help to treat fatty liver disease and reduce the number of severe cases. This is the finding of researchers from the University of Barcelona (UB) ...
Drinking as little as one can of diet soda a day may increase the risk of nonalcohol fatty liver disease by 60%, while drinking a sugary beverage could raise the risk by 50%, a new unpublished study ...
University of Victoria provides funding as a member of The Conversation CA-FR. University of Victoria provides funding as a member of The Conversation CA. Research has revealed a steep increase in ...
Alcohol doesn’t just damage the liver — it locks its cells in a strange “in-between” state that prevents them from healing. Even after someone quits drinking, liver cells often get stuck, unable to ...
Roche targets liver disease treatments with acquisition Deal includes $14.50 a share, potential milestone payments up to $6.00 a share Roche flags potential to treat obesity-related conditions The ...